diabetes and more
Follow
Find
32.2K views | +11 today
diabetes and more
Important news for those concerned with all types of diabetes, associated autoimmune diseases, & health
Your new post is loading...
Your new post is loading...
Scooped by Ellen H Ullman, MSW
Scoop.it!

Former office manager, a diabetic, sues Casper company for discrimination

Former office manager, a diabetic, sues Casper company for discrimination | diabetes and more | Scoop.it

.....On Oct. 26, 2009, she was in the company’s parking lot when she experienced her first and only serious hypoglycemic episode, was taken to the hospital, treated for low blood sugar, and released, according to the complaint.
After that incident, Mackey became hostile toward her, according to the complaint.
On Dec. 8, he asked Mauser to retire because of her “’medical condition’” and Groathouse owners’ concerns she might have another low blood sugar reaction, according to the complaint.
She refused, saying she loved her job and was able to perform it despite her disability, according to the complaint.
Mackey’s hostility increased with condescending remarks, berating her in front of other employees, and he made it difficult for her to schedule medical appointments, according to the complaint. He did not treat men with disabilities harshly and hostilely, according to the complaint.

Read more: http://trib.com/news/local/casper/former-office-manager-a-diabetic-sues-casper-company-for-discrimination/article_a3ff8a47-ee7a-5be4-a1fa-e3d751020d2f.html#ixzz1lblWmVW6

 

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Wiley: The Knowledgeable Patient: Communication and Participation in Health

Wiley: The Knowledgeable Patient: Communication and Participation in Health | diabetes and more | Scoop.it

A video by the author explaining more about the book can be seen here:  http://www.youtube.com/watch?v=1MqDkTXI1qA 

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Activist Post: FDA Whistleblower Lawsuit Sparks Congressional Investigation

Activist Post: FDA Whistleblower Lawsuit Sparks Congressional Investigation | diabetes and more | Scoop.it

"Targeted monitoring has a devastating chilling effect on all public employees, strangling the ability of the American public and Congress to learn about misconduct and corruption in the federal government."

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Insulin-Induced Lipohypertrophy — NEJM

Insulin-Induced Lipohypertrophy — NEJM | diabetes and more | Scoop.it
Images in Clinical Medicine from The New England Journal of Medicine — Insulin-Induced Lipohypertrophy (RT @NEJM: Image in Clinical Medicine: Insulin-Induced Lipohypertrophy http://t.co/DcT0OODg...)...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Living Well with Chronic Illness: A Call for Public Health Action - Institute of Medicine

Living Well with Chronic Illness: A Call for Public Health Action - Institute of Medicine | diabetes and more | Scoop.it
The epidemic of chronic illness is steadily moving towards crisis proportions, yet maintaining or enhancing quality of life for individuals living with these illnesses has not been given the attention it deserves.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Environmental Health Perspectives: Obesogens: An Environmental Link to Obesity

Environmental Health Perspectives: Obesogens: An Environmental Link to Obesity | diabetes and more | Scoop.it

Obesity has risen steadily in the United States over the past 150 years,1 with a marked uptick in recent decades.2 In the United States today more than 35% of adults3 and nearly 17% of children aged 2–19 years are obese.4 Obesity plagues people not just in the United States but worldwide, including, increasingly, developing countries.5 Even animals—pets, laboratory animals, and urban rats—have experienced increases in average body weight over the past several decades,6 trends not necessarily explained by diet and exercise. In the words of Robert H. Lustig, a professor of clinical pediatrics at the University of California, San Francisco, “[E]ven those at the lower end of the BMI [body mass index] curve are gaining weight. Whatever is happening is happening to everyone, suggesting an environmental trigger.”7

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

DexCom and Tandem Diabetes Care Announce CGM Development and Commercialization Agreement | Business Wire

DexCom and Tandem Diabetes Care Announce CGM Development and Commercialization Agreement | Business Wire | diabetes and more | Scoop.it
DexCom and Tandem Diabetes Care Announce CGM Development and Commercialization Agreement...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Draft Guidance for Industry and Food and Drug Administration Staff; the Content of Investigational Device Exemption and Premarket Approval Applications for Artificial Pancreas Device Systems

Draft Guidance for Industry and Food and Drug Administration Staff; the Content of Investigational Device Exemption and Premarket Approval Applications for Artificial Pancreas Device Systems; Availability
This draft guidance document provides industry and the Agency staff with guidelines for developing premarket submissions for artificial pancreas device systems, in particular, the Control-to-Range (CTR) and Control-to-Target (CTT) device systems. Comments due by March 5, 2012.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Regulations.gov Food and Drug Administration Decisions for Investigational Device Exemption (IDE) Clinical Investigations; Extension of Comment Period

SUMMARY: The Food and Drug Administration (FDA) is extending the
comment period for the notice that appeared in the Federal Register of
Thursday, November, 10, 2011 (76 FR 70151). In the notice, FDA
requested comments on the draft guidance that has been developed to
promote the initiation of clinical investigations to evaluate the
medical devices under FDA's Investigational Device Exemptions (IDE)
regulations. The Agency is taking this action to allow interested
persons additional time to submit comments.

DATES: Submit written or electronic comments and information by March
9, 2012.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Device Makers Said to Double FDA Fees to Produce Faster Reviews

Medical device makers will double the fees they pay U.S. regulators to get their products reviewed over the next five years, to $595 million, in a deal designed to secure faster and more predictable evaluations, say two people with knowledge of the talks.
The pact with the Food and Drug Administration, which must be authorized by Congress, replaces one that cost Medtronic Inc. (MDT), Johnson & Johnson and other device makers $295 million over the last five years, and expires on Sept. 30. The people who confirmed the fees asked not to be identified because they’re not authorized to speak on the record.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

MyInfo911 Introduces New Emergency Key Tag ID Card to its Impressive Line Of State of the Art Emergency ID Products To Assist Victims of Vehicular Accidents

MyInfo911 Introduces New Emergency Key Tag ID Card to its Impressive Line Of State of the Art Emergency ID Products To Assist Victims of Vehicular Accidents | diabetes and more | Scoop.it
Myinfo 911 has added a new Key Tag ID Card to its present array of state of the art medical ID products in its efforts to provide even greater protection to victims of vehicular accidents and other medical emergencies, ensuring they receive care...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

New Actavis / Bioton Alliance To Shake Up Diabetes Market - TheStreet

Actavis and Bioton (WSE:BIO) announced today that they have formed a joint venture company for the development and registration of insulins, including analogue insulins. Within the framework of the joint-venture, Bioton will be responsible for the development and manufacture of insulin products, while Actavis will be granted an exclusive licence to commercialise those products under the Actavis brand throughout the European Union and the United States of America, as well as in Albania, Bosnia & Herzegovina, Croatia, Iceland, Japan, Kosovo, Lichtenstein, Macedonia, Montenegro, Norway, Serbia and Switzerland. In Poland, both companies will offer the insulin products under their respective brands, Bioton being a Polish company.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Iodide Heart Scans Linked to Thyroid Disease

Iodide Heart Scans Linked to Thyroid Disease | diabetes and more | Scoop.it
A common iodide contrast agent given to millions of patients who undergo medical scans every year raises the risk of thyroid disease, a new study shows.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Boehringer to research cause of diabetes with German university - NEWS - General articles - Pharmaceutical Industry - PMLiVE

Pharmaceutical Industry | NEWS | General | Boehringer to research cause of diabetes with German university - Five-year collaboration with TU Dresden will also look at link between high blood sugar levels and diabetes complications | PMLiVE...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Diabetes Working Group releases recommendations for eliminating obstacles to diabetes care

Diabetes Working Group releases recommendations for eliminating obstacles to diabetes care | diabetes and more | Scoop.it
The Diabetes Working Group, composed of representatives from various medical associations, recently released a white paper containing recommenda...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Distinguish Type 1 From Type 2 Diabetes in Obese Youth : Family Practice News

Distinguish Type 1 From Type 2 Diabetes in Obese Youth : Family Practice News | diabetes and more | Scoop.it
STEAMBOAT SPRINGS, COLO. – New-onset type 1 diabetes in an obese youth cannot reliably be distinguished from pediatric type 2 diabetes on clinical grounds in this era of epidemic obesity.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

PharmTech Talk » FDA Gives Biosimilars Update

PharmTech Talk » FDA Gives Biosimilars Update | diabetes and more | Scoop.it

FDA Gives Biosimilars Update
Published by Angie Drakulich on February 3, 2012 02:39 pm under Biotech, Regulation, Uncategorized
Rachel Sherman, MD, Associate Director for Medical Policy, within FDA’s Center for Drug Evaluation and Research, gave a press briefing today. Below is a summary.

In terms of background, the BPCI Act was passed in March 2010 as part of Affordable Care Act, and it creates an abbreviated licensure pathway for biological products shown to be biosimilar or interchangeable with an FDA-licensed reference product (section 351k of Public Health Service Act). FDA is eager to have an informational discussion on this topic because with the new pathway program, the agency is “essentially launching an entirely new regulatory paradigm” and public needs to understand this, said Sherman....

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

New White Paper on Obstacles to Diabetes Care

New White Paper on Obstacles to Diabetes Care | diabetes and more | Scoop.it

Overview

Through new research sponsored by the Diabetes Working Group, this white paper examines provider barriers to offering the current standards of diabetes care and offers recommendations to mitigate these barriers. To better understand these issues, the DWG undertook the following initiatives:

A comprehensive literature review of peer-reviewed articles on current standards of diabetes care, outcomes evidence, and current health economics data of diabetes care and treatment;
A provider survey fielded to a large sample of diabetes care providers in the United States, with an objective of identifying barriers for diabetes providers to providing optimal diabetes care; and
A theoretical Standards of Care Delivery Model designed to estimate the necessary resources to consistently deliver the current standards of care to diabetes patients in the United States. The model illustrates the gap between the current provision of care and what is needed to improve patient outcomes to meet current guidelines.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

College Living :: Diabetes Self-Management

College Living :: Diabetes Self-Management | diabetes and more | Scoop.it
Hello, Diabetes Self-Management community! This is my first blog post for DSM, and I am absolutely ecstatic to be writing for them. Aside from my love of writing and general obsession with blogs, I love talking about diabetes.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

EPA Misses Deadline on Dioxin Guidelines

EPA Misses Deadline on Dioxin Guidelines | diabetes and more | Scoop.it
The EPA missed a deadline to release federal guidelines on the dangers of excess dioxin chemicals in the food supply and environment, giving ammunition to critics that hope the agency will change course.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Breakthrough in Duration of Continuous Monitoring Action in Type 1 Diabetics

Breakthrough in Duration of Continuous Monitoring Action in Type 1 Diabetics | diabetes and more | Scoop.it
EyeSense AG today announced positive results from a Clinical study involving Type I Diabetic patients conducted at Heidelberg University in Germany that mark a key milestone in the Company's efforts to revolutionize...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Partnership Between Lilly Diabetes and the American Diabetes Association to Send 89 Children to American Diabetes Association Diabetes Camps in 2012

Partnership Between Lilly Diabetes and the American Diabetes Association to Send 89 Children to American Diabetes Association Diabetes Camps in 2012 | diabetes and more | Scoop.it

Partnership Between Lilly Diabetes and the American Diabetes Association to Send 89 Children to American Diabetes Association Diabetes Camps in 2012
Provides children from low-income families the opportunity to learn important diabetes management skills in a fun and safe environment

INDIANAPOLIS and ALEXANDRIA, Va., Feb. 1, 2012 /PRNewswire via COMTEX/ -- Lilly Diabetes today announced its commitment to send 89 children to diabetes camp this summer through a collaboration with the American Diabetes Association (Association)

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

New cards designed to encourage people living with diabetes,PTSD & chronic pain...- Santa Cruz Sentinel

SANTA CRUZ - Amy Sibiga, a UC Santa Cruz College Eight alum, is back on campus.The cards she designed to encourage people living with diabetes, post-traumatic stress disorder and chronic pain are in stock at UCSCs bookstore.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Medical: Blood, urine testing faces new competition

Medical: Blood, urine testing faces new competition | diabetes and more | Scoop.it
Collecting blood and urine specimens can often be messy or painful for patients. And for legally sensitive tests, such as for drugs or alcohol, ensuring the sample's integrity demands close supervision at the expense of privacy.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval

Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval | diabetes and more | Scoop.it
The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the drug might contribute to heart rhythm abnormalities.
more...
No comment yet.